[ad_1]
Behind the first company that announced success in the coronavirus (Covid-19) vaccine, Prof. Dr. Uğur Şahin and his wife, Dr. Is Özlem Türeci. After the announcement of a 90 percent effective vaccine in stopping the coronavirus, scientists broke the good news that they would return to normal in the spring. The world press brought the success of the Turkish couple to the headlines.
THE BIONTECH CORONAVIRUS VACCINE BEGAN ITS STUDY IN MID-JANUARY
BioNTech’s BNT162b2 vaccine, which has been in development since mid-January, began a 3-phase trial study, which is vital for its approval, in several countries in late July.
The coronavirus vaccine developed by BioNTech and Pfizer has been announced to be more than 90 percent effective against Covid-19 disease. While the results were claimed to be positive in 90 percent of the volunteers tested with the vaccine developed against the coronavirus (Covid-19), there were no serious safety concerns in the volunteers tested. The company’s second tests will be announced this weekend. Whether the vaccine has protective effects and side effects will be determined over a two-year period.
RETURN TO NORMAL UNTIL SPRING
The Times newspaper noted that after the coronavirus vaccine, it could return to normal until spring. Professor of Health of the British Government. Dr Jonathan Van-Tam said that after this big tipping point (Covid-19 vaccine), the wave of coronavirus infection meant that the UK could be the last to endure.
DREAM TEAM
The Guardian newspaper, Prof. Dr. Uğur Şahin and Dr. Bringing Özlem Türeci’s achievements to the headline, used the words ‘The dream team behind the vaccine’
The article included the following statements: “As the world breathed with relief, Uğur Şahin and Özlem Türeci showed characteristic humility at the news that the experimental vaccine developed by BioNTech and Pfizer showed positive results in the third stage trials.
Uğur cyclingahin, CEO of BioNTech, known for cycling to the headquarters of a company valued at $ 21.9 billion, said the results of the vaccine trial were above all “a victory in innovation, science and a collaborative effort. global”. Hopefully this will help the world ‘regain a sense of normalcy.’
THE TREATY, BUSINESS ETHICS AND THE ENTREPRENEURIAL SPIRIT LEAVE MORE ROOTED COMPETITORS
The Guardian emphasized that Şahin and Türeci left the more established competitors behind in the Covid-19 vaccine race, claiming that the comments pointed to scientific rigor, business ethics and entrepreneurship. He noted that the couple was ranked 93rd on the list of the richest people in Germany this fall.
The vaccine found by UĞUR TÜRECİ AND ÖZLEM TÜRECİ IS CANDIDATE FOR NOBEL
Prof. Dr. Uğur Şahin and his wife, Dr. Özlem Türeci’s coronavirus vaccine study found will be nominated for the Nobel Prize in Germany.
“THE BEST NEWS I HAVE RECEIVED SINCE JANUARY 10”
“These are excellent results. Efficacy could be higher than expected, and that probably means, in the US at least, that there will be a request for approval very soon. Frankly, this is the best I’ve had since 10 January, “said Florian Krammer, a professor of microbiology at Mount Sinai University. news “found in the description.
“THIS IS A VERY GOOD RESULT”
“This is a very good result. Non-serious side effects have been reported. Overall, a very positive result. This will likely lead to early approval,” said Bernd Salzberger, head of the Department of Infectiology at the University of Regensburg.
“THE RESULTS OF EFFICIENCY AND SAFETY ARE EXCELLENT”
Head of the Department of Infectious Diseases at the University of Cologne, Prof. Dr. Gerd Faetkenheuer said: “This is excellent and promising data. The development of a vaccine in such a short period of time is incredible and clinical trials have been achieved in a few months. So far, the efficacy and safety results are excellent. I hope the vaccine will have a great impact on the management of the pandemic and the vaccine will be rapid, “he said.
HERE IS THE PRICE OF THE CORONAVIRUS VACCINE
The price of the coronavirus vaccine developed by BioNTech and Pfizer will be TL 159 per dose, based on prices in the US.
